World of DTC Marketing

JUNE 27, 2021

Wegovy’s most common side effects were gastrointestinal problems, including nausea, diarrhea, and vomiting, which 80% of patients reported, according to USA Today. Novo’s PR department did a great job and most articles about the drug did talk about the side effects but how many people really read that deep?

Side effects 194

Side effects Patients Insurance Doctors 194

World of DTC Marketing

FEBRUARY 4, 2021

million, his first big raise since 2015, thanks to incentive pay that jumped by about $1.2 prescriptions of finasteride, as the drug is known, for hair loss increased to over 2.4 million in 2020, more than double the number in 2015, according to health data company IQVIA. million while the company’s pipe line falters.

Pharma 180

Pharma Food and Drug Administration Side effects Safety 180

World of DTC Marketing

MARCH 19, 2021

There are many reasons why people don’t take their medications, including cost and medication side effects but that’s only part of the picture. This results in 20% to 30% of prescriptions for chronic medical conditions never being filled, and at least half of these medications not being taken as prescribed.

Healthcare 143

Healthcare Healthcare Side effects Medical 143

pharmaphorum

NOVEMBER 25, 2022

The phase 2 ZENITH20 study showed an objective response rate (ORR) of 28% with a median duration of response of around five months, and 12% of patients had to discontinue therapy due to side effects. Spectrum licensed worldwide rights to poziotinib – excluding Korea and China – from Hanmi in back in 2015.

FDA 96

FDA Side effects Prescription Recruitment 96

Pharmaceutical Technology

JULY 23, 2008

Between 2003 and 2005 global sales for cancer-treating drugs grew by 40% According to IMS Health, who tracks prescription drug sales, the global market for cancer drugs is still growing rapidly with around $48bn spent on oncology products in 2008; a figure which accounts for 17% of worldwide pharmaceutical sales. .”

Side effects 52

Side effects Marketing Pharmaceutical Sales 52

Pharmaceutical Technology

OCTOBER 10, 2022

In 2015, the FDA approved Sprout Pharmaceuticals’s Addyi, also known under the generic name flibanserin, for use by pre-menopausal women with hypoactive sexual desire disorder (HSDD). Moreover, despite the buzz generated when Addyi was launched in 2015, only one other drug has since been marketed.

Pharmacology 59

Pharmacology Side effects FDA Safety 59